• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT MITRACLIP SYSTEM STEERABLE GUIDE CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT MITRACLIP SYSTEM STEERABLE GUIDE CATHETER Back to Search Results
Catalog Number SGC0302
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Death (1802); Hemorrhage/Bleeding (1888); Low Blood Pressure/ Hypotension (1914); Perforation (2001)
Event Date 04/13/2018
Event Type  Death  
Manufacturer Narrative
(b)(4).The customer reported the steerable guide catheter was discarded.Investigation is not yet complete.A follow up report will be submitted with all additional relevant information.
 
Event Description
This is filed to report the patient death.It was reported that on (b)(6) 2018 the mitraclip procedure was intended to be performed in the patient with a fragile state of health and grade 4 degenerative mitral regurgitation (mr).At the start of the procedure, the arterial pressure was approximately 9 to 10 mm hg.During advancement of the steerable guide catheter (sgc), the femoral vein was perforated.There was no resistance felt during advancement of the sgc through the femoral vein, but it is surmised that the physician applied too much force to the sgc during advancement and it went too far and the guide wire was not kept straight during advancement.The procedure was aborted and no mitraclip was implanted due to this adverse event.The arterial pressure dropped down to 3 mm hg.The bleeding was controlled by keeping the sgc in place while the patient was transferred to surgery to repair the femoral lesion.A covered stent was placed and the perforation was sutured.After surgery, the arterial pressure increased to 12 mm hg.The patient expired on (b)(6) 2018 from an unknown cause.There was no issue reported with the device.No additional information was provided.
 
Manufacturer Narrative
(b)(4).The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot.The reported patient effects of hemorrhage, hypotension, cardiac perforation and death as listed in the mitraclip nt system instructions for use, are known possible complications associated with mitraclip procedures.This event was further reviewed by an abbott vascular medical affairs director.The reviewer concluded that the procedure was conducted in a patient in a fragile condition and led to a complication during advancement of the sgc (steerable guide catheter) resulting in femoral vein complication.Despite surgical repair of the vascular complication; the patient died the following day.It is likely that the bleeding and the surgical procedure further compromised the patients hemodynamic state, ultimately leading to death.This fatal event was procedure-related but not device-related as the procedure was aborted with no clip implanted.It appears that the fragile patient condition together with the procedural complication during advancement of the sgc resulted in the perforation of the femoral vein; the hemorrhage was a result of the perforation; hypotension was related to the combination of the bleeding and the surgical procedure.The mitraclip procedure combined with the cascading patient effects listed above contributed to the patients subsequent death.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITRACLIP SYSTEM STEERABLE GUIDE CATHETER
Type of Device
STEERABLE GUIDE CATHETER
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer (Section G)
MENLO PARK, CA REG# 3005070406
abbott vascular
26531 ynez rd.
temecula CA 92591 4628
Manufacturer Contact
connie speck
abbott vascular
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key7492859
MDR Text Key107555758
Report Number2024168-2018-03368
Device Sequence Number1
Product Code DRA
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K161985
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Remedial Action Other
Type of Report Initial,Followup
Report Date 07/03/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/21/2018
Device Catalogue NumberSGC0302
Device Lot Number70821U140
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/13/2018
Initial Date FDA Received05/07/2018
Supplement Dates Manufacturer Received06/28/2018
Supplement Dates FDA Received07/03/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/01/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
-
-